ArticleMedicine2021

Microvascular invasion may be the determining factor in selecting TACE as the initial treatment in patients with hepatocellular carcinoma.

Joonho Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.